BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260621
DTEND;VALUE=DATE:20260622
DTSTAMP:20260608T042333
CREATED:20260501T115213Z
LAST-MODIFIED:20260501T115213Z
UID:10321-1782000000-1782086399@thebiocalendar.com
SUMMARY:2026 SoCal TBA 10th Anniversary Symposium: AI\, Biotech & VC at UCLA
DESCRIPTION:Celebrate 10 years of biotech innovation at UCLA. Explore the future of AI in medicine with VCs\, founders\, and industry leaders. \n\n\n\n\nFor the past decade\, SoCal TBA has connected the biotech communities of Southern California and Taiwan. This year’s theme\, “From Foundations to Frontiers: AI\, Innovation\, and the Future of Biomedicine\,” brings together leaders in venture capital\, biotech startups\, academia\, and industry to explore how AI is transforming the future of medicine. \nWhether you are a founder\, investor\, scientist\, student\, or biotech professional\, this symposium is designed to help you build relationships\, discover new ideas\, and stay ahead of where the industry is going next.
URL:https://thebiocalendar.com/event/2026-socal-tba-10th-anniversary-symposium-ai-biotech-vc-at-ucla/
LOCATION:Los Angeles\, Los Angeles\, CA\, United States
CATEGORIES:Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260608T042333
CREATED:20251121T160254Z
LAST-MODIFIED:20251121T160254Z
UID:9564-1782086400-1782431999@thebiocalendar.com
SUMMARY:BIO 2026
DESCRIPTION:The industry’s premier event hosts thousands from across the global biotech ecosystem. Four days of programming\, networking\, Company Presentations\, and BIO Partnering™ focus on the future of our industry and make this a must-attend event. \n\n\n\n\n\n\nBIO 2026 is where we return to this essential “why.” It is our opportunity to reconnect as a global community\, to recharge our commitment\, and to remember that behind every innovation is a shared mission: to improve lives.
URL:https://thebiocalendar.com/event/bio-2026/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Investor,Networking,Partnering,Summit,Trade Show
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260622T110000
DTEND;TZID=America/Los_Angeles:20260622T120000
DTSTAMP:20260608T042333
CREATED:20260521T162343Z
LAST-MODIFIED:20260522T081936Z
UID:10504-1782126000-1782129600@thebiocalendar.com
SUMMARY:From Variable to Predictable: How Intensified Upstream Processing Improves Scale-Up and Tech Transfer
DESCRIPTION:As biomanufacturers face increasing pressure to boost productivity\, reduce costs\, and accelerate timelines\, traditional scale-up approaches can introduce variability and performance drift. Intensified upstream processing offers a more scalable\, efficient path forward—helping maintain product quality\, process stability\, and regulatory compliance from development through GMP manufacturing. \nIn this webinar\, Thermo Fisher Scientific experts share best practices and real-world insights on implementing intensified upstream strategies\, supported by advanced automation\, process analytical technologies (PAT)\, and data-driven control. \nIn this session\, you will learn how to:\n~ Drive productivity with intensification strategies\n~ Accelerate timelines using high-density inoculation and optimized seed trains\n~ Increase output through perfusion and hybrid processing models\n~ Improve consistency with automation\, PAT\, and real-time control\n~ Enable reliable scale-up with standardized tech transfer approaches \nKey challenges addressed:\n~ Performance drift and variability during scale-up\n~ Limited productivity with traditional processes\n~ Long development and seed train timelines\n~ Inconsistent results across sites \nDiscover how intensified upstream processing can help you scale with confidence while improving efficiency\, consistency\, and speed across your operations.
URL:https://thebiocalendar.com/event/from-variable-to-predictable-how-intensified-upstream-processing-improves-scale-up-and-tech-transfer/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-22-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260622T110000
DTEND;TZID=America/Los_Angeles:20260622T120000
DTSTAMP:20260608T042333
CREATED:20260528T121901Z
LAST-MODIFIED:20260528T121901Z
UID:10536-1782126000-1782129600@thebiocalendar.com
SUMMARY:Driving Faster Clinical Trial Setup: How Humans and AI Collaborate to Improve Quality\, Speed\, and Agility in Study Build
DESCRIPTION:Study build inefficiency is rarely caused by a single failure point. Instead\, delays accumulate across fragmented protocol interpretation\, manual configuration\, iterative amendments\, and validation cycles that often surface issues late—when they are more costly to resolve. For many sponsors and CROs\, this has become the accepted baseline. The more important question is whether it needs to be. \nThis webinar explores how a more integrated human–AI collaboration model can address these challenges. Drawing on practical experience from study build environments\, we examine how AI can be applied not just to automate individual tasks\, but to support the full lifecycle—from protocol interpretation through configuration and validation. In this model\, AI contributes context-aware support grounded in clinical data structures and study design logic\, while clinical and operational experts guide decisions\, validate outputs\, and ensure regulatory alignment. \nWe will share how this approach is being implemented in practice\, including where AI can help reduce rework\, improve consistency in configuration\, and surface potential downstream issues earlier in the process. Particular focus will be given to how teams are balancing increased speed with the need for control\, auditability\, and quality. \nThrough real-world examples and live demonstration segments\, attendees will gain a practical understanding of how human expertise and AI can work together to improve study build performance—enabling faster timelines while maintaining rigor. \nWhy attend:\n– Gain a realistic\, experience-based perspective on AI in clinical operations\n– See how these approaches are being applied within active study environments\n– Understand how to improve speed without compromising quality or oversight
URL:https://thebiocalendar.com/event/driving-faster-clinical-trial-setup-how-humans-and-ai-collaborate-to-improve-quality-speed-and-agility-in-study-build/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-22-26-Endpoint-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260622T130000
DTEND;TZID=America/Los_Angeles:20260622T150000
DTSTAMP:20260608T042333
CREATED:20260507T200048Z
LAST-MODIFIED:20260507T200048Z
UID:10403-1782133200-1782140400@thebiocalendar.com
SUMMARY:Venture Hub Showcase: International Pitch Event at BIO 2026
DESCRIPTION:Biocom is pleased to announce our upcoming Venture Hub Showcase—an international pitch event taking place during the 2026 BIO International Convention. This event offers a valuable opportunity to connect with potential strategic partners and investors\, while exploring the latest life science innovations from fellow industry leaders. Light snacks and refreshments will be provided.
URL:https://thebiocalendar.com/event/venture-hub-showcase-international-pitch-event-at-bio-2026/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T100000
DTEND;TZID=America/Los_Angeles:20260623T140000
DTSTAMP:20260608T042333
CREATED:20260511T125601Z
LAST-MODIFIED:20260522T081902Z
UID:10405-1782208800-1782223200@thebiocalendar.com
SUMMARY:Bio-Expo Live: Upstream Bioprocessing
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Upstream Manufacturing session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers essential to therapeutic areas from ADCs to vaccines. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available products/solutions to help them overcome upstream manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-upstream-bioprocessing-4/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-BEL-1280x720-upstream-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T110000
DTEND;TZID=America/Los_Angeles:20260623T120000
DTSTAMP:20260608T042333
CREATED:20260519T145520Z
LAST-MODIFIED:20260522T081837Z
UID:10461-1782212400-1782216000@thebiocalendar.com
SUMMARY:Mastering Inspection: Strategies to Reduce Downtime and Ensure Quality
DESCRIPTION:This webinar explores why inspection in HMLV environments is inherently challenging and identifies the most common pain points faced by operations\, engineering\, and quality teams.
URL:https://thebiocalendar.com/event/mastering-inspection-strategies-to-reduce-downtime-and-ensure-quality/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-23-26-Koerber-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T130000
DTEND;TZID=America/Los_Angeles:20260623T140000
DTSTAMP:20260608T042333
CREATED:20260526T130313Z
LAST-MODIFIED:20260526T130313Z
UID:10508-1782219600-1782223200@thebiocalendar.com
SUMMARY:Automating cell therapy manufacturing without redesigning established workflows
DESCRIPTION:As cell therapy programs transition into clinical development\, manufacturing teams face increasing pressure to automate workflows while preserving biological performance and hard-earned process knowledge. Many teams hesitate to introduce automation due to concerns around forced process redesign\, loss of flexibility\, or risks to clinical timelines. \nIn this webinar\, Cytiva specialists will demonstrate how the Sefia™ cell therapy manufacturing platform enables closed\, automated processing without requiring changes to existing media\, reagents\, or core process logic. Using real workflow learnings and development examples\, the speakers will explore how automation can be introduced incrementally to support clinical readiness today while preparing for future scale. \nAttendees will gain practical guidance on mapping their current workflows to an automation-ready platform\, reducing operational risk\, and building a clear path from development to GMP manufacturing. \nKey learning objectives: \n    Understand how to automate cell therapy workflows without redesigning biology\n    Identify platform features that support clinical readiness and future scale\n    Learn how closed\, modular systems reduce operational risk while preserving flexibility
URL:https://thebiocalendar.com/event/automating-cell-therapy-manufacturing-without-redesigning-established-workflows/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T203000
DTEND;TZID=America/Los_Angeles:20260623T233000
DTSTAMP:20260608T042333
CREATED:20260507T200213Z
LAST-MODIFIED:20260508T105803Z
UID:10404-1782246600-1782257400@thebiocalendar.com
SUMMARY:Golden Hour | Biocom Reception at #BIO2026
DESCRIPTION:During the 2026 BIO International Convention\, join Biocom for its highly anticipated Member-Only Bash in partnership with IQHQ—an unforgettable evening bringing together the global life science community. \nThis highly anticipated event brings together professionals from around the world for a dynamic evening of networking\, collaboration\, and celebration. Set against a stunning waterfront backdrop\, Biocom’s BIO Bash offers a unique opportunity to connect with industry leaders\, exchange ideas\, and engage with innovators shaping the future of life sciences. \nEvent Highlights \n\nGlobal audience of life science leaders and innovators\nHigh-impact networking in a vibrant\, social setting\nUnique waterfront venue experience\nCelebration of innovation and industry achievements\n\nMark your calendar for an evening filled with energy\, connection\, and collaboration—an essential gathering during one of the industry’s most influential weeks.
URL:https://thebiocalendar.com/event/golden-hour-biocom-reception-at-bio2026/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T100000
DTEND;TZID=America/Los_Angeles:20260624T140000
DTSTAMP:20260608T042333
CREATED:20260511T125831Z
LAST-MODIFIED:20260522T081810Z
UID:10409-1782295200-1782309600@thebiocalendar.com
SUMMARY:Bio-Expo Live: Downstream Bioprocessing
DESCRIPTION:During the 2026 BIO International Convention\, join Biocom for its highly anticipated Member-Only Bash in partnership with IQHQ—an unforgettable evening bringing together the global life science community. \nThis highly anticipated event brings together professionals from around the world for a dynamic evening of networking\, collaboration\, and celebration. Set against a stunning waterfront backdrop\, Biocom’s BIO Bash offers a unique opportunity to connect with industry leaders\, exchange ideas\, and engage with innovators shaping the future of life sciences. \nEvent Highlights \n\nGlobal audience of life science leaders and innovators\nHigh-impact networking in a vibrant\, social setting\nUnique waterfront venue experience\nCelebration of innovation and industry achievements\n\nMark your calendar for an evening filled with energy\, connection\, and collaboration—an essential gathering during one of the industry’s most influential weeks.
URL:https://thebiocalendar.com/event/bio-expo-live-downstream-bioprocessing-3/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-BEL-1280x720-downstream-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T110000
DTEND;TZID=America/Los_Angeles:20260624T120000
DTSTAMP:20260608T042333
CREATED:20260528T121712Z
LAST-MODIFIED:20260528T121712Z
UID:10532-1782298800-1782302400@thebiocalendar.com
SUMMARY:Global Regulatory Compliance for Aseptic Barrier Systems
DESCRIPTION:As sterile pharmaceutical manufacturing evolves\, isolators and Restricted Access Barrier Systems (RABS) have become central to contamination control strategies across global markets. Yet regulatory expectations from the FDA\, EU GMP Annex 1\, PIC/S\, and WHO differ in meaningful ways\, from legal enforceability to technical prescriptiveness\, creating compliance complexity for manufacturers supplying multiple markets. \nThis webinar provides a structured comparison of the four major regulatory frameworks governing aseptic barrier systems\, examining where they converge on scientific fundamentals and where they diverge in documentation requirements\, monitoring expectations\, and treatment of advanced technologies. Special focus will be given to the 2022 revision of EU GMP Annex 1 and its harmonized adoption across PIC/S and WHO. \nAttendees will leave with a clearer understanding of how to design and qualify barrier systems that satisfy both the principle-based flexibility of the FDA and the structured minimum standards of the EU/PIC/S/WHO model\, supporting a robust\, globally acceptable contamination control strategy. \nKEY LEARNING OBJECTIVES \n– Understand how FDA\, EU GMP Annex 1\, PIC/S\, and WHO align and differ in their requirements for isolators\, RABS\, and contamination control strategy documentation\n– Identify the practical compliance implications of regulatory divergence for manufacturers operating across multiple jurisdictions\n– Apply a risk-based framework for barrier system design\, decontamination validation\, and environmental monitoring that satisfies global inspection expectations
URL:https://thebiocalendar.com/event/global-regulatory-compliance-for-aseptic-barrier-systems/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-24-26-Esco-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260625T100000
DTEND;TZID=America/Los_Angeles:20260625T140000
DTSTAMP:20260608T042333
CREATED:20260511T130147Z
LAST-MODIFIED:20260522T081737Z
UID:10413-1782381600-1782396000@thebiocalendar.com
SUMMARY:Bio-Expo Live: Bioprocess Quality\, Data\, & Analytical Solutions
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Data\, Quality\, & Analytical session will have the chance to explore the latest equipment and solutions offered by our presenting suppliers essential to biopharmaceutical development and manufacturing. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available quality\, data\, and/or analytical products/solutions to help them overcome their manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-bioprocess-quality-data-analytical-solutions-3/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-BEL-1280x720-BQDA-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260625T110000
DTEND;TZID=America/Los_Angeles:20260625T120000
DTSTAMP:20260608T042333
CREATED:20260526T130939Z
LAST-MODIFIED:20260526T212741Z
UID:10516-1782385200-1782388800@thebiocalendar.com
SUMMARY:False Rejects Aren’t Inevitable: How to Reduce Waste and Improve Line Efficiency
DESCRIPTION:False rejects are more than a nuisance—they create unnecessary waste\, disrupt production efficiency\, and erode confidence in inspection systems. \nIn this webinar\, we will explore the top 10 causes of false rejects across system setup\, environmental conditions\, and product and operational variability. We will also demonstrate why false rejects are not inevitable\, but instead indicators of correctable issues. \nAttendees will gain insight into how false rejects may affect yield\, throughput\, compliance\, and brand reputation. We’ll also explore a range of practical considerations that can help minimize false rejects\, including system setup\, environmental conditions\, and day-to-day operational practices. \nThe webinar will conclude with a simple\, actionable checklist to help teams drive consistent\, reliable performance on the production line. \nKey Learning Objectives: \nIdentify the most common causes of false rejects and their impact on efficiency\, quality\, and compliance\nApply practical strategies to stabilize systems\, control environmental factors\, and reduce variability\nImplement a structured approach and checklist to systematically reduce false rejects and improve line performance
URL:https://thebiocalendar.com/event/false-rejects-arent-inevitable-how-to-reduce-waste-and-improve-line-efficiency/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-25-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260625T110000
DTEND;TZID=America/Los_Angeles:20260625T120000
DTSTAMP:20260608T042333
CREATED:20260602T165807Z
LAST-MODIFIED:20260602T165917Z
UID:10567-1782385200-1782388800@thebiocalendar.com
SUMMARY:From AI Hype to Oversight Confidence: Accelerating Clinical Data Review Without Losing Control
DESCRIPTION:In this webinar\, Revvity Signals will explore how Signals Clinical applies governed\, fit-for-purpose AI within clinical data review workflows. The discussion will focus on practical ways to accelerate review while keeping clinical experts in control.
URL:https://thebiocalendar.com/event/from-ai-hype-to-oversight-confidence-accelerating-clinical-data-review-without-losing-control/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/06-25-26-Revvity-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T110000
DTEND;TZID=America/Los_Angeles:20260630T120000
DTSTAMP:20260608T042333
CREATED:20260529T135221Z
LAST-MODIFIED:20260529T135221Z
UID:10553-1782817200-1782820800@thebiocalendar.com
SUMMARY:The Evolution and Future of Targeted Protein Degradation Chemistry
DESCRIPTION:Once a fringe idea in chemical biology\, targeted protein degradation (TPD) has become one of the most watched strategies in drug discovery. TPD has created new therapeutic opportunities for previously undruggable protein targets. Leading experts will discuss the design\, challenges\, and clinical promise of PROTACs in overcoming limitations of traditional small molecules.  \nEver wonder: \nHow have PROTACS\, molecular glues\, and linker chemistries and their related research and development evolved over the past 20 years? \nHow we decide on the right modality and MoA?  \nWhich discovery technologies are available to us?  \nHow do they translate from animals to humans?  \nHow are companies and academic groups approaching safety assessment for degraders\, particularly with respect to off‑target effects\, tissue specificity\, and long‑term protein knockdown? \nJoin us to get some answers directly from field experts.
URL:https://thebiocalendar.com/event/the-evolution-and-future-of-targeted-protein-degradation-chemistry/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T120000
DTEND;TZID=America/Los_Angeles:20260630T130000
DTSTAMP:20260608T042333
CREATED:20260528T122037Z
LAST-MODIFIED:20260528T122037Z
UID:10540-1782820800-1782824400@thebiocalendar.com
SUMMARY:Residual DNA testing across biotherapeutics: dPCR workflows and a CDMO perspective
DESCRIPTION:Residual host cell DNA (residual DNA) is a critical quality attribute across biologics\, vaccines and advanced therapy modalities\, requiring sensitive and reproducible quantification to support process development\, in-process control and lot release. However\, traditional workflows can introduce variability and delay release timelines due to reliance on standard curves\, multiple manual steps and method complexity. \nIn this webinar\, we will outline digital PCR (dPCR) workflows and performance for residual DNA analysis across a range of expression systems\, including Vero\, Sf9/Baculovirus\, Pichia pastoris\, mouse\, HEK293\, CHO and E. coli. We will discuss how a standardized dPCR approach can simplify method deployment across diverse programs. \nKBI Biopharma will share real-life perspectives on implementing dPCR-based residual DNA workflows for CHO- and E. coli-derived programs\, including considerations for sample preparation and data interpretation. The session will also explore how extraction-free dPCR workflows can streamline in-process monitoring and lot release testing\, enabling faster decision-making and improved manufacturing efficiency. The webinar will conclude with practical guidance on assay selection and integration of residual DNA testing into development and manufacturing workflows. \nLearning objectives:\n– Understand dPCR-based residual DNA workflows and performance across multiple expression systems\n– Evaluate how dPCR can improve workflow efficiency and data quality\, including accuracy\, linearity\, and reduced turnaround time\n– Learn from a CDMO case study on implementing residual DNA testing\, including comparison to qPCR and the impact of extraction-free workflows on in-process monitoring and lot release
URL:https://thebiocalendar.com/event/residual-dna-testing-across-biotherapeutics-dpcr-workflows-and-a-cdmo-perspective/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-30-26-Qiagen-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T110000
DTEND;TZID=America/Los_Angeles:20260701T120000
DTSTAMP:20260608T042333
CREATED:20260529T171302Z
LAST-MODIFIED:20260529T171302Z
UID:10556-1782903600-1782907200@thebiocalendar.com
SUMMARY:A Closer Look at How Single Use Consumables Drive Cost per Therapy
DESCRIPTION:This virtual event will examine manufacturing pain points from process development through commercialization\, showing how value driven single use consumable design from the outset helps prevent issues across each stage.
URL:https://thebiocalendar.com/event/a-closer-look-at-how-single-use-consumables-drive-cost-per-therapy/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/07-01-26-Invetech-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T110000
DTEND;TZID=America/Los_Angeles:20260701T120000
DTSTAMP:20260608T042333
CREATED:20260605T200441Z
LAST-MODIFIED:20260605T200441Z
UID:10574-1782903600-1782907200@thebiocalendar.com
SUMMARY:A Closer Look at How Single Use Consumables Drive Cost per Therapy
DESCRIPTION:The discussion will examine key manufacturing challenges and highlight where consumables add value\, where they introduce unnecessary complexity\, and how early upstream and downstream decisions impact long-term cost\, scalability\, and risk. Attendees will leave with key points to consider on how to approach consumables as a strategic part of manufacturing\, rather than a line-item cost.
URL:https://thebiocalendar.com/event/a-closer-look-at-how-single-use-consumables-drive-cost-per-therapy-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-01-26-Invetech-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T130000
DTEND;TZID=America/Los_Angeles:20260701T140000
DTSTAMP:20260608T042333
CREATED:20260528T173004Z
LAST-MODIFIED:20260528T173004Z
UID:10545-1782910800-1782914400@thebiocalendar.com
SUMMARY:Reducing Particulate-Related Batch Risk in Bioprocessing: Moving from Detection to Prevention
DESCRIPTION:Rising regulatory expectations and increased scrutiny around particulate contamination are reshaping how risk is managed in bioprocessing. Particulate issues are often identified late in the process\, leading to operational disruption\, rework\, and increased validation burden. \nThis webinar explores how organizations can shift from reactive responses to proactive containment strategies. Using aggregated industry insights and representative case patterns\, we’ll examine where issues occur\, their operational impact\, and how low and ultra-low particulate container solutions can help reduce risk earlier and improve process reliability.
URL:https://thebiocalendar.com/event/reducing-particulate-related-batch-risk-in-bioprocessing-moving-from-detection-to-prevention/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/07-01-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260712
DTEND;VALUE=DATE:20260716
DTSTAMP:20260608T042333
CREATED:20260504T221447Z
LAST-MODIFIED:20260504T221447Z
UID:10334-1783814400-1784159999@thebiocalendar.com
SUMMARY:Alzheimer's Association International Conference®
DESCRIPTION:Join distinguished basic scientists\, clinical researchers\, early career investigators\, clinicians and the care research community at the largest international conference on dementia science. Share theories\, breakthroughs and best practices while exploring opportunities to accelerate your work and elevate your career.
URL:https://thebiocalendar.com/event/alzheimers-association-international-conference-4/
LOCATION:London\, London\, United Kingdom
CATEGORIES:Academic Research
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260713
DTEND;VALUE=DATE:20260716
DTSTAMP:20260608T042333
CREATED:20251215T154751Z
LAST-MODIFIED:20251215T154751Z
UID:9649-1783900800-1784159999@thebiocalendar.com
SUMMARY:Global Biotech CEO Summit
DESCRIPTION:The Global Biotech CEO Summit\, unlike most meetings CEOs attend\, is not an investor conference nor is it a business development conference. Rather\, the Summit’s focus is on the challenges CEOs face in this rapidly changing environment and the obstacles they face leading their companies. The program is modeled after a think tank-style meeting with discussions led by subject matter experts with input from the CEOs. The CEOs benefit from the wisdom and experiences shared by other participating CEOs and the discussants. \nThe Summit operates under the Chatham House Rule to encourage open and frank conversations. The number of participants is limited to allow full engagement. Participation is gated; you have to apply to join this exclusive group. The Summit is closed to media and the sessions are not recorded in order to provide an extra layer of privacy. \nIf you are the CEO of a biotech company and are interested in attending this gathering\, please send an email to info@demy-colton.com with your contact details and a link to your company website. The organizers will respond quickly.
URL:https://thebiocalendar.com/event/global-biotech-ceo-summit/
LOCATION:Napa Valley\, Napa\, CA\, 94559\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260713
DTEND;VALUE=DATE:20260717
DTSTAMP:20260608T042333
CREATED:20260603T113752Z
LAST-MODIFIED:20260603T113752Z
UID:10572-1783900800-1784246399@thebiocalendar.com
SUMMARY:The AAPS Summer Scientific Forum
DESCRIPTION:AAPS\, the convener of the pharmaceutical industry\, brings scientists working in pharmaceutical analysis and bioanalysis together in the Summer Scientific Forum. Dive deep into the latest research in these areas\, then cross-connect with other scientists in shared high-level sessions focused on regulatory issues that impact both disciplines. Discuss all of it in networking events designed to bring together all attendees.
URL:https://thebiocalendar.com/event/the-aaps-summer-scientific-forum/
LOCATION:Columbus\, Columbus\, OH\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260715
DTEND;VALUE=DATE:20260720
DTSTAMP:20260608T042333
CREATED:20260504T221817Z
LAST-MODIFIED:20260504T221817Z
UID:10337-1784073600-1784505599@thebiocalendar.com
SUMMARY:BIO Asia–Taiwan 2026
DESCRIPTION:BIO Asia–Taiwan 2026 will be held July 15-19 at the TaiNEX 1 & 2 halls\, Nangang Exhibition Center\, Taipei. The event brings together bioindustry executives and investors from North America\, Europe and Asia to explore business opportunities and to engage with Taiwan’s growing biotech sector. The five-day gathering includes a three-day conference featuring 250+ internationally-renowned speakers\, company presentations from Asia and around the world\, BIO Partnering™ meetings\, a full program of symposia and workshops\, and an international exhibition.
URL:https://thebiocalendar.com/event/bio-asia-taiwan-2026/
LOCATION:Taipei\, Taipei\, Taiwan
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260717T163000
DTEND;TZID=America/Los_Angeles:20260717T183000
DTSTAMP:20260608T042333
CREATED:20260504T221610Z
LAST-MODIFIED:20260504T221610Z
UID:10335-1784305800-1784313000@thebiocalendar.com
SUMMARY:Richmond BioHub Biotech & Beer
DESCRIPTION:The Richmond-Petersburg region is home to a dynamic network of biotech\, pharma\, medical device\, healthcare\, and life science professionals — and it’s also one of the best places in the country for craft beer lovers. \nJoin us for a Biotech & Beer\, a relaxed and lively networking event bringing together innovators from start-ups\, academia\, and industry\, alongside our regional ecosystem builders. Whether you’re a scientist\, entrepreneur\, investor\, or simply passionate about advancing life sciences in our region\, this is the perfect setting to make meaningful connections and enjoy great conversation over local brews. \nLet’s celebrate the power of collaboration — and good beer — in growing our biotech community.
URL:https://thebiocalendar.com/event/richmond-biohub-biotech-beer/
LOCATION:Richmond\, Richmond\, VA\, United States
CATEGORIES:Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260723T130000
DTEND;TZID=America/Los_Angeles:20260723T190000
DTSTAMP:20260608T042333
CREATED:20260601T133038Z
LAST-MODIFIED:20260601T133038Z
UID:10563-1784811600-1784833200@thebiocalendar.com
SUMMARY:MALSI Day 2026
DESCRIPTION:The 19th annual Massachusetts Life Sciences Innovation (MALSI) Day is the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-energy\, hands-on\, global event which brings together scientific leaders and business experts to mingle with scientists\, post-docs\, professors\, entrepreneurs\, innovators\, and venture capitalists. \nThe day features panel discussions\, emerging technology spinout showcase / pitches\, and features Tech Transfer Office startups and a networking reception. \nIt is the flagship event of life sciences in Massachusetts\, jointly and actively put together by the Massachusetts Life Sciences Center\, BioLabs\, LabCentral\, MassVentures and The Engine\, in partnership with many other major organizations supporting the life sciences start-up ecosystem in the Commonwealth.
URL:https://thebiocalendar.com/event/malsi-day-2026/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Networking,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260726
DTEND;VALUE=DATE:20260731
DTSTAMP:20260608T042333
CREATED:20260501T114859Z
LAST-MODIFIED:20260501T114859Z
UID:10318-1785024000-1785455999@thebiocalendar.com
SUMMARY:ADLM Annual Meeting
DESCRIPTION:July 26-30\, 2026 \nAnaheim Convention Center\nAnaheim\, CA\, USA \nSpeak your mind. Now accepting abstracts – inspire a global lab med community with your brilliance at #ADLM26. Accepted presenters will be part of a globally acclaimed scientific program. \nADLM 2026 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) is a program of the Association for Diagnostics & Laboratory Medicine (ADLM). Great minds converge to discuss the latest science and prepare for what’s next in the field. Experience all this and more: \n\nConnect with global leaders in clinical chemistry\, molecular diagnostics\, mass spectrometry\, translational medicine\, lab management\, and other areas of breaking science in laboratory medicine.\nLearn about cutting edge technology at the ADLM Clinical Lab Expo featuring 750+ exhibitors and 200+ new products/services.\nHear vital research and learn about important changes in the field. With more than 250 educational opportunities in the form of lectures\, plenary sessions\, scientific sessions\, and roundtable sessions\, you can design an educational experience that meets your need to stay ahead of changes in the field.\n\nStart planning today. Save when you register early — registration is now open!
URL:https://thebiocalendar.com/event/adlm-annual-meeting/
LOCATION:Anaheim\, Anaheim\, CA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260810
DTEND;VALUE=DATE:20260814
DTSTAMP:20260608T042333
CREATED:20260316T091025Z
LAST-MODIFIED:20260516T074742Z
UID:10023-1786320000-1786665599@thebiocalendar.com
SUMMARY:The Bioprocessing Summit 2026
DESCRIPTION:Elevate your expertise\, embrace innovation\, and join the global leaders who are transforming the future of bioprocessing. \nNow in its 18th year\, the Bioprocessing Summit unites a global community of scientists\, engineers\, and executives driving innovation and digitalization across process development\, scale-up\, quality\, and analytics for biologics\, antibodies\, cell and gene\, RNA\, and oligonucleotide therapies. \nExplore how technology\, data\, and AI are reshaping every stage of the bioprocessing journey — Transforming Bioprocessing for the Digital Age
URL:https://thebiocalendar.com/event/the-bioprocessing-summit-2026/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Featured,Summit
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/03/bps-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260824
DTEND;VALUE=DATE:20260827
DTSTAMP:20260608T042333
CREATED:20260511T225230Z
LAST-MODIFIED:20260511T225230Z
UID:10419-1787529600-1787788799@thebiocalendar.com
SUMMARY:Next Generation Dx Summit
DESCRIPTION:Breakthrough Tech. Expert Insights. Real-World Impact. \n\n400+ diagnostics professionals from across the industry\n120+ speakers leading innovation in clinical and molecular Dx\n6 highly focused tracks spanning emerging technologies and commercial strategy\nUnmatched networking with partners\, labs\, regulators\, and investors\nEmerging company spotlight with novel platform technologies\n\nNext Generation Dx Summit is where the diagnostics ecosystem converges to accelerate innovation and expand patient access \n\n\n\n\nGain the latest insights in: \n\nClinical implementation and validation of diagnostic technologies\nPoint-of-care innovation and at-home testing\nEarly detection and enhanced screening of single cancers and MCEDs\nAI\, digital\, and emerging applications in companion diagnostics\nAI in lab management\, testing\, clinical decision support\, and analysis
URL:https://thebiocalendar.com/event/next-generation-dx-summit-3/
LOCATION:Washington\, DC\, Washington\, DC\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
DTSTAMP:20260608T042333
CREATED:20260504T221917Z
LAST-MODIFIED:20260504T221917Z
UID:10339-1788134400-1788220799@thebiocalendar.com
SUMMARY:ESC Congress 2026
DESCRIPTION:Join us and experience transformation through practice\, policy\, responsibility and genuine human connection. \nThis year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot\, enhancing precision\, speed\, and safety in patient care. Discover AI in action\, from diagnosis to delivery\, through hands-on sessions\, live demonstrations\, and immersive learning. \nHere we will explore a diverse range of topics\, uniting all subspecialties to create a space to share breakthrough data and debate new ideas\, before applying innovation to real-world settings. \nThis is where collaboration becomes progress\, and transformation is not just seen\, but felt.
URL:https://thebiocalendar.com/event/esc-congress-2026/
LOCATION:Munich\, Munich\, Bavaria\, Germany
CATEGORIES:Seminar,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260916
DTSTAMP:20260608T042333
CREATED:20260504T222100Z
LAST-MODIFIED:20260504T222100Z
UID:10340-1789344000-1789516799@thebiocalendar.com
SUMMARY:Drug Delivery & Formulation Summit
DESCRIPTION:The 16th American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry’s best speakers\, with technical experts\, industry leaders\, and specialists providing an unmissable two days of the latest information. \nNow in its 16th year\, the summit continues to go from strength to strength. Last year saw a record number of attendees with over 450 scientific leaders from pharma\, biotech\, and drug delivery industries. \nThose in attendance will benefit from a packed two-day programme\, where they will explore the critical issues with the industry’s best speakers. There will be plentiful networking times\, expect to meet fellow industry leaders\, enabling meetings\, connections\, and business growth.
URL:https://thebiocalendar.com/event/drug-delivery-formulation-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
END:VCALENDAR